Evidence map›Paper›PMID 40606454›Full record

ArticleFrontiers in medicine2025

Case Report: Anaphylactic shock induced by cefoperazone sodium and sulbactam sodium for injection.

Weiqian Liu, Bo Gao, Shaowei Xie, Dongrui Yan, Yu Yin

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Weiqian LiuDepartment of Rehabilitation Medicine, Hebei General Hospital, Shijiazhuang, China.
Bo GaoDepartment of Urinary Surgery, Hebei General Hospital, Shijiazhuang, China.
Shaowei XieDepartment of Rehabilitation Medicine, Hebei General Hospital, Shijiazhuang, China.
Dongrui YanDepartment of Rehabilitation Medicine, Hebei General Hospital, Shijiazhuang, China.
Yu YinDepartment of Rehabilitation Medicine, Hebei General Hospital, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Cefoperazone-sulbactam is a widely used antibiotic in clinical practice, and anaphylactic shock is a severe adverse drug reaction. Previous literature has rarely reported cases of anaphylactic shock induced by cefoperazone-sulbactam. Patient concerns: A 38-year-old male patient who underwent surgery for cerebral hemorrhage developed fever, with considerations of pulmonary and urinary tract infections. Following the administration of injectable cefoperazone-sulbactam, he experienced anaphylactic shock. Diagnosis: Anaphylactic shock was suspected to be caused by injectable cefoperazone-sulbactam. Interventions: The patient was administered a subcutaneous injection of 1 mg epinephrine, followed by continuous infusion of 10 mg norepinephrine in 45 mL of 5% glucose solution via a pump. Additionally, assisted ventilation with a respirator and fluid resuscitation were provided. Outcome: The patient was discharged with improved symptoms. Lessons: To prevent serious adverse reactions, it is essential to strictly adhere to indications and contraindications to avoid misuse and minimize the occurrence of adverse effects. Prior to medication administration, a thorough inquiry into the patient's drug allergy history and family history should be conducted.

Indexed as

adverse drug reactionsanaphylactic shockantibioticscase reportinjectable cefoperazone-sulbactam

Identifiers

PMID40606454
PMCPMC12213337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.